Hitting KRAS When It's Down.
2020
KRAS, one of the most prevalent oncogenes and sought-after anticancer targets, has eluded chemists for decades until an irreversible covalent strategy targeting a specific mutation (G12C) paved the...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
6
References
3
Citations
NaN
KQI